hsa-mir-369: Hsa-mir-369 is a hub DE miRNA that has been identified through the interaction of DE lncRNAs-miRNAs, miRNAs-DE mRNAs, and DE miRNAs [PMC8176956]. It is part of a miRNA cluster in the human Dlk1/Gtl2 domain at chromosome 14q32, along with hsa-miR-127 [PMC3404966]. While hsa-mir-369's involvement in cancer is not yet documented, it has been found to play a role in translational efficiency on cell cycle exit under growth arrest conditions [PMC3404966]. Hsa-mir-369 has been identified as a potential target for FOXO1, along with hsa-mir-135b and hsa-mir-324 [PMC5356276]. In the context of medical information from patients, hsa-mir-369 has been predicted as one of the five miRNAs that could be considered as molecular targets for prognosis prediction [PMC4627364]. A mathematical model for miRNA and survival time was constructed using Cox multivariate regression model, and hsa-mir-369 was included in the prognosis formula along with other selected miRNAs [PMC4627364]. Additionally, PLCG1 has been identified as a potential target of hsa-mir-369 among other miRNAs [PMC7146847]. Overall, while there is limited documentation on its involvement in cancer, hsa-mir-369 shows potential as a molecular target for prognosis prediction and may play a role in translational efficiency under growth arrest conditions.